Literature DB >> 29855423

What works to increase attendance for diabetic retinopathy screening? An evidence synthesis and economic analysis.

John G Lawrenson1, Ella Graham-Rowe2, Fabiana Lorencatto2, Stephen Rice3, Catey Bunce4, Jill J Francis2, Jennifer M Burr5, Patricia Aluko3, Luke Vale3, Tunde Peto6, Justin Presseau7,8, Noah M Ivers9, Jeremy M Grimshaw7,10.   

Abstract

BACKGROUND: Diabetic retinopathy screening (DRS) is effective but uptake is suboptimal.
OBJECTIVES: To determine the effectiveness of quality improvement (QI) interventions for DRS attendance; describe the interventions in terms of QI components and behaviour change techniques (BCTs); identify theoretical determinants of attendance; investigate coherence between BCTs identified in interventions and determinants of attendance; and determine the cost-effectiveness of QI components and BCTs for improving DRS. DATA SOURCES AND REVIEW
METHODS: Phase 1 - systematic review of randomised controlled trials (RCTs) evaluating interventions to increase DRS attendance (The Cochrane Library, MEDLINE, EMBASE and trials registers to February 2017) and coding intervention content to classify QI components and BCTs. Phase 2 - review of studies reporting factors influencing attendance, coded to theoretical domains (MEDLINE, EMBASE, PsycINFO and sources of grey literature to March 2016). Phase 3 - mapping BCTs (phase 1) to theoretical domains (phase 2) and an economic evaluation to determine the cost-effectiveness of BCTs or QI components.
RESULTS: Phase 1 - 7277 studies were screened, of which 66 RCTs were included in the review. Interventions were multifaceted and targeted patients, health-care professionals (HCPs) or health-care systems. Overall, interventions increased DRS attendance by 12% [risk difference (RD) 0.12, 95% confidence interval (CI) 0.10 to 0.14] compared with usual care, with substantial heterogeneity in effect size. Both DRS-targeted and general QI interventions were effective, particularly when baseline attendance levels were low. All commonly used QI components and BCTs were associated with significant improvements, particularly in those with poor attendance. Higher effect estimates were observed in subgroup analyses for the BCTs of 'goal setting (outcome, i.e. consequences)' (RD 0.26, 95% CI 0.16 to 0.36) and 'feedback on outcomes (consequences) of behaviour' (RD 0.22, 95% CI 0.15 to 0.29) in interventions targeting patients and of 'restructuring the social environment' (RD 0.19, 95% CI 0.12 to 0.26) and 'credible source' (RD 0.16, 95% CI 0.08 to 0.24) in interventions targeting HCPs. Phase 2 - 3457 studies were screened, of which 65 non-randomised studies were included in the review. The following theoretical domains were likely to influence attendance: 'environmental context and resources', 'social influences', 'knowledge', 'memory, attention and decision processes', 'beliefs about consequences' and 'emotions'. Phase 3 - mapping identified that interventions included BCTs targeting important barriers to/enablers of DRS attendance. However, BCTs targeting emotional factors around DRS were under-represented. QI components were unlikely to be cost-effective whereas BCTs with a high probability (≥ 0.975) of being cost-effective at a societal willingness-to-pay threshold of £20,000 per QALY included 'goal-setting (outcome)', 'feedback on outcomes of behaviour', 'social support' and 'information about health consequences'. Cost-effectiveness increased when DRS attendance was lower and with longer screening intervals. LIMITATIONS: Quality improvement/BCT coding was dependent on descriptions of intervention content in primary sources; methods for the identification of coherence of BCTs require improvement.
CONCLUSIONS: Randomised controlled trial evidence indicates that QI interventions incorporating specific BCT components are associated with meaningful improvements in DRS attendance compared with usual care. Interventions generally used appropriate BCTs that target important barriers to screening attendance, with a high probability of being cost-effective. Research is needed to optimise BCTs or BCT combinations that seek to improve DRS attendance at an acceptable cost. BCTs targeting emotional factors represent a missed opportunity to improve attendance and should be tested in future studies. STUDY REGISTRATION: This study is registered as PROSPERO CRD42016044157 and PROSPERO CRD42016032990. FUNDING: The National Institute for Health Research Health Technology Assessment programme.

Entities:  

Mesh:

Year:  2018        PMID: 29855423      PMCID: PMC6004544          DOI: 10.3310/hta22290

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN: 1366-5278            Impact factor:   4.014


  12 in total

1.  Combining diabetic foot and retinopathy screening: A step in the right direction? - a feasibility study.

Authors:  Jane Ea Lewis; Keith Morris; Thomas Powell; Rebecca L Thomas; David R Owens
Journal:  SAGE Open Med       Date:  2020-07-28

2.  Reducing catheter-associated urinary tract infections: a systematic review of barriers and facilitators and strategic behavioural analysis of interventions.

Authors:  Lou Atkins; Anna Sallis; Tim Chadborn; Karen Shaw; Annegret Schneider; Susan Hopkins; Amanda Bunten; Susan Michie; Fabiana Lorencatto
Journal:  Implement Sci       Date:  2020-07-06       Impact factor: 7.327

3.  Feasibility of an implementation intervention to increase attendance at diabetic retinopathy screening: protocol for a cluster randomised pilot trial.

Authors:  Fiona Riordan; Emmy Racine; Susan M Smith; Aileen Murphy; John Browne; Patricia M Kearney; Colin Bradley; Mark James; Mark Murphy; Sheena M McHugh
Journal:  Pilot Feasibility Stud       Date:  2020-05-12

4.  Development of an intervention to facilitate implementation and uptake of diabetic retinopathy screening.

Authors:  Fiona Riordan; Emmy Racine; Eunice T Phillip; Colin Bradley; Fabiana Lorencatto; Mark Murphy; Aileen Murphy; John Browne; Susan M Smith; Patricia M Kearney; Sheena M McHugh
Journal:  Implement Sci       Date:  2020-05-19       Impact factor: 7.327

5.  Health education improves referral compliance of persons with probable Diabetic Retinopathy: A randomized controlled trial.

Authors:  Zara Khair; Md Moshiur Rahman; Kana Kazawa; Yasmin Jahan; Abu S G Faruque; Mohammod Jobayer Chisti; Michiko Moriyama
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

Review 6.  Organizational aspect in healthcare decision-making: a literature review.

Authors:  Amélie Dubromel; Marie-Audrey Duvinage-Vonesch; Loïc Geffroy; Claude Dussart
Journal:  J Mark Access Health Policy       Date:  2020-08-31

7.  A micro costing analysis of the development of a primary care intervention to improve the uptake of diabetic retinopathy screening.

Authors:  Susan Ahern; Fiona Riordan; Aileen Murphy; John Browne; Patricia M Kearney; Susan M Smith; Sheena M McHugh
Journal:  Implement Sci       Date:  2021-02-10       Impact factor: 7.327

8.  Longitudinal Screening for Diabetic Retinopathy in a Nationwide Screening Program: Comparing Deep Learning and Human Graders.

Authors:  Jirawut Limwattanayingyong; Variya Nganthavee; Kasem Seresirikachorn; Tassapol Singalavanija; Ngamphol Soonthornworasiri; Varis Ruamviboonsuk; Chetan Rao; Rajiv Raman; Andrzej Grzybowski; Mike Schaekermann; Lily H Peng; Dale R Webster; Christopher Semturs; Jonathan Krause; Rory Sayres; Fred Hersch; Richa Tiwari; Yun Liu; Paisan Ruamviboonsuk
Journal:  J Diabetes Res       Date:  2020-12-15       Impact factor: 4.011

9.  Implementation for Sustained Impact in Teleophthalmology (I-SITE): applying the NIATx Model for tailored implementation of diabetic retinopathy screening in primary care.

Authors:  Alejandra Torres Diaz; Loren J Lock; Todd D Molfenter; Jane E Mahoney; Deanne Boss; Timothy D Bjelland; Yao Liu
Journal:  Implement Sci Commun       Date:  2021-07-06

10.  Identifying Barriers and Enablers to Attending Diabetic Retinopathy Screening in Immigrants to Canada From Ethnocultural Minority Groups: Protocol for a Qualitative Descriptive Study.

Authors:  Maman Joyce Dogba; Michael H Brent; Catherine Bach; Sarah Asad; Jeremy Grimshaw; Noah Ivers; France Légaré; Holly O Witteman; Janet Squires; Xiaoqin Wang; Olivera Sutakovic; Mary Zettl; Olivia Drescher; Zack van Allen; Nicola McCleary; Marie-Claude Tremblay; Stefanie Linklater; Justin Presseau
Journal:  JMIR Res Protoc       Date:  2020-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.